Actemra ACTPen (tocilizumab) — NDC 50242-143 by Genentech, Inc.
Actemra ACTPen (tocilizumab) — NDC 50242-143 by Genentech, Inc. is one of 9,000 drug products in the NDCLookup dataset. Key details — Brand name: Actemra ACTPen; Generic name: tocilizumab; Product NDC: 50242-143.
| Brand name | Actemra ACTPen |
|---|---|
| Generic name | tocilizumab |
| Product NDC | 50242-143 |
| Labeler | Genentech, Inc. |
| Dosage form | INJECTION, SOLUTION |
| Route | SUBCUTANEOUS |
| Active ingredients | TOCILIZUMAB 162 mg/.9mL |
| Pharmacologic class | Interleukin 6 Receptor Antagonists [MoA], Interleukin-6 Receptor Antagonist [EPC] |
| Marketing category | BLA |
| Product type | HUMAN PRESCRIPTION DRUG |
| Source | openFDA NDC Directory |
$899/mo
Try NDCLookup →